The tumor inhibition was accompanied with an increased frequency of myeloid cells positive for CD11b+ and CD11c+ within the tumor draining lymph nodes, a heightened infiltration of CD8+ effector T and natural killer (NK) cells, and a maintained presence of neutrophils at the tumor site. The gene discussed is ITGAX; the disease is neoplasm.